IL119080A - Rapidly disintegrating pharmaceutical preparations containing unbound tramadol - Google Patents

Rapidly disintegrating pharmaceutical preparations containing unbound tramadol

Info

Publication number: IL119080A
Authority: IL; Israel
Prior art keywords: tramadol; tablets; disintegration; water; starch
Prior art date: 1995-08-19

Application number

IL11908096A

Other languages

English (en)

Hebrew (he)

Other versions

IL119080A0 (en

Original Assignee

Gruenenthal Chemie

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-08-19

Filing date

1996-08-16

Publication date

2001-07-24

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7769912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL119080(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-08-16 Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie

1996-11-14 Publication of IL119080A0 publication Critical patent/IL119080A0/xx

2001-07-24 Publication of IL119080A publication Critical patent/IL119080A/en

Links

TVYLLZQTGLZFBW-ZBFHGGJFSA-N (R,R)-tramadol Chemical compound COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-ZBFHGGJFSA-N 0.000 title claims abstract description 34
229960004380 tramadol Drugs 0.000 title claims abstract description 18
TVYLLZQTGLZFBW-GOEBONIOSA-N tramadol Natural products COC1=CC=CC([C@@]2(O)[C@@H](CCCC2)CN(C)C)=C1 TVYLLZQTGLZFBW-GOEBONIOSA-N 0.000 title claims abstract description 18
239000008194 pharmaceutical composition Substances 0.000 title description 2
229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 16
229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 16
235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 16
239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 16
229920002472 Starch Polymers 0.000 claims description 14
235000019698 starch Nutrition 0.000 claims description 14
239000008107 starch Substances 0.000 claims description 13
239000003795 chemical substances by application Substances 0.000 claims description 11
239000000470 constituent Substances 0.000 claims description 3
235000019589 hardness Nutrition 0.000 description 18
239000004480 active ingredient Substances 0.000 description 14
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 10
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
PPKXEPBICJTCRU-XMZRARIVSA-N (R,R)-tramadol hydrochloride Chemical compound Cl.COC1=CC=CC([C@]2(O)[C@H](CCCC2)CN(C)C)=C1 PPKXEPBICJTCRU-XMZRARIVSA-N 0.000 description 7
229960003107 tramadol hydrochloride Drugs 0.000 description 7
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 6
244000246386 Mentha pulegium Species 0.000 description 5
235000016257 Mentha pulegium Nutrition 0.000 description 5
235000004357 Mentha x piperita Nutrition 0.000 description 5
240000004760 Pimpinella anisum Species 0.000 description 5
235000012550 Pimpinella anisum Nutrition 0.000 description 5
239000011230 binding agent Substances 0.000 description 5
229940079593 drug Drugs 0.000 description 5
239000003814 drug Substances 0.000 description 5
235000001050 hortel pimenta Nutrition 0.000 description 5
235000019359 magnesium stearate Nutrition 0.000 description 5
239000000463 material Substances 0.000 description 5
239000000377 silicon dioxide Substances 0.000 description 5
229920002261 Corn starch Polymers 0.000 description 4
235000019759 Maize starch Nutrition 0.000 description 4
239000000203 mixture Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
229930195725 Mannitol Natural products 0.000 description 3
235000010980 cellulose Nutrition 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
230000007423 decrease Effects 0.000 description 3
230000000694 effects Effects 0.000 description 3
239000000594 mannitol Substances 0.000 description 3
235000010355 mannitol Nutrition 0.000 description 3
239000002245 particle Substances 0.000 description 3
229920002785 Croscarmellose sodium Polymers 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
239000001913 cellulose Substances 0.000 description 2
235000013339 cereals Nutrition 0.000 description 2
238000005056 compaction Methods 0.000 description 2
235000019700 dicalcium phosphate Nutrition 0.000 description 2
230000001079 digestive effect Effects 0.000 description 2
239000000945 filler Substances 0.000 description 2
239000000796 flavoring agent Substances 0.000 description 2
235000011389 fruit/vegetable juice Nutrition 0.000 description 2
239000008101 lactose Substances 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
239000002609 medium Substances 0.000 description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
230000008092 positive effect Effects 0.000 description 2
238000003825 pressing Methods 0.000 description 2
239000007787 solid Substances 0.000 description 2
238000006467 substitution reaction Methods 0.000 description 2
239000000725 suspension Substances 0.000 description 2
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
108010011485 Aspartame Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
229920003085 Kollidon® CL Polymers 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
230000000202 analgesic effect Effects 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
239000000605 aspartame Substances 0.000 description 1
235000010357 aspartame Nutrition 0.000 description 1
IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
229960003438 aspartame Drugs 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
229960005069 calcium Drugs 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 description 1
229940062672 calcium dihydrogen phosphate Drugs 0.000 description 1
229910000389 calcium phosphate Inorganic materials 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
HFNCOTSLOKKPHU-UHFFFAOYSA-N cyclohexanol;hydrochloride Chemical compound Cl.OC1CCCCC1 HFNCOTSLOKKPHU-UHFFFAOYSA-N 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
239000011363 dried mixture Substances 0.000 description 1
239000013583 drug formulation Substances 0.000 description 1
235000013399 edible fruits Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
210000004051 gastric juice Anatomy 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
239000008187 granular material Substances 0.000 description 1
239000003979 granulating agent Substances 0.000 description 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
235000015122 lemonade Nutrition 0.000 description 1
239000007788 liquid Substances 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019691 monocalcium phosphate Nutrition 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
239000001267 polyvinylpyrrolidone Substances 0.000 description 1
239000003755 preservative agent Substances 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
229960001462 sodium cyclamate Drugs 0.000 description 1
238000003756 stirring Methods 0.000 description 1
238000003860 storage Methods 0.000 description 1
230000009747 swallowing Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)
Cosmetics (AREA)

IL11908096A 1995-08-19 1996-08-16 Rapidly disintegrating pharmaceutical preparations containing unbound tramadol IL119080A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19530575A DE19530575A1 (de)	1995-08-19	1995-08-19	Schnell zerfallende Arzneiform von Tramadol oder einem Tramadolsalz

Publications (2)

Publication Number	Publication Date
IL119080A0 IL119080A0 (en)	1996-11-14
IL119080A true IL119080A (en)	2001-07-24

Family

ID=7769912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11908096A IL119080A (en)	1995-08-19	1996-08-16	Rapidly disintegrating pharmaceutical preparations containing unbound tramadol

Country Status (28)

Country	Link
US (1)	US5776492A (pl)
EP (1)	EP0759296B1 (pl)
JP (1)	JP4074675B2 (pl)
CN (1)	CN1102385C (pl)
AR (1)	AR003476A1 (pl)
AT (1)	ATE205708T1 (pl)
AU (1)	AU703310B2 (pl)
BR (1)	BR9604034A (pl)
CA (1)	CA2182939C (pl)
CZ (1)	CZ289167B6 (pl)
DE (2)	DE19530575A1 (pl)
DK (1)	DK0759296T3 (pl)
ES (1)	ES2164198T3 (pl)
GR (1)	GR3036720T3 (pl)
HU (1)	HU227360B1 (pl)
IL (1)	IL119080A (pl)
MY (1)	MY113908A (pl)
NO (1)	NO313486B1 (pl)
NZ (1)	NZ299141A (pl)
PE (1)	PE8298A1 (pl)
PL (1)	PL184785B1 (pl)
PT (1)	PT759296E (pl)
RU (1)	RU2174837C2 (pl)
SI (1)	SI0759296T1 (pl)
SK (1)	SK281779B6 (pl)
UA (1)	UA41392C2 (pl)
UY (1)	UY24308A1 (pl)
ZA (1)	ZA966985B (pl)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100389752C (zh) *	1978-04-21	2008-05-28	莱博法姆公司	控释组合物
US5989589A (en) *	1997-10-24	1999-11-23	Cartilier; Louis	Cross-linked cellulose as a tablet excipient
EP1058538B9 (en) *	1998-03-06	2013-01-02	Aptalis Pharma S.r.l.	Fast disintegrating tablets
SE9802973D0 (sv) *	1998-09-03	1998-09-03	Astra Ab	Immediate release tablet
DE19901683B4 (de) *	1999-01-18	2005-07-21	Grünenthal GmbH	Analgetikum mit kontrollierter Wirkstofffreisetzung
DE19901686A1 (de) *	1999-01-18	2000-07-20	Gruenenthal Gmbh	Retardierte Tramadolzubereitungen mit einem lagerstabilen Freisetzungsprofil und Verfahren zu deren Herstellung
GB9904911D0 (en) *	1999-03-03	1999-04-28	Scherer Ltd R P	Pharmaceutical compositions
DE19940740A1 (de) *	1999-08-31	2001-03-01	Gruenenthal Gmbh	Pharmazeutische Salze
CA2388560A1 (en)	1999-08-31	2001-03-08	Grunenthal Gmbh	Sustained-release form of administration containing tramadol saccharinate
DE50008261D1 (de) *	1999-08-31	2004-11-18	Gruenenthal Gmbh	Retardierte darreichungsform enthaltend tramadolsaccharinat
DE19940944B4 (de)	1999-08-31	2006-10-12	Grünenthal GmbH	Retardierte, orale, pharmazeutische Darreichungsformen
RU2174836C1 (ru) *	2000-12-15	2001-10-20	Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин"	Фармацевтическая композиция, обладающая анальгезирующим действием
AU2003275855B2 (en) *	2002-10-25	2009-04-23	Paladin Labs (Barbados) Inc.	Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en)	2002-10-25	2013-07-16	Paladin Labs Inc.	Controlled-release compositions
PT1558935E (pt) *	2002-10-25	2008-10-16	Labopharm Inc	Composições de libertação controlada
CN1942175B (zh) *	2002-10-25	2010-05-26	莱博法姆公司	24小时有效的曲马多缓释制剂
TWI319713B (en)	2002-10-25	2010-01-21		Sustained-release tramadol formulations with 24-hour efficacy
US20040265375A1 (en) *	2003-04-16	2004-12-30	Platteeuw Johannes J.	Orally disintegrating tablets
AR045637A1 (es)	2003-09-12	2005-11-02	Amgen Inc	Formulacion de disolucion rapida de un compuesto activo frente a los receptores de calcio
US20060172006A1 (en) *	2003-10-10	2006-08-03	Vincent Lenaerts	Sustained-release tramadol formulations with 24-hour clinical efficacy
ES2255429B1 (es) *	2004-10-25	2007-08-16	Italfarmaco, S.A.	Composiciones farmaceuticas bucodispersables.
US8022053B2 (en) *	2004-11-02	2011-09-20	Bayer Schering Pharma Aktiengesellschaft	Oral solid dosage forms containing a low dose of estradiol
ES2620293T3 (es)	2005-09-09	2017-06-28	Paladin Labs Inc.	Composición de liberación sostenida de fármacos
SI1931346T1 (sl) *	2005-09-09	2012-10-30	Angelini Labopharm Llc	Trazodonski sestavek za dajanje enkrat dnevno
US20090004248A1 (en) *	2007-06-29	2009-01-01	Frank Bunick	Dual portion dosage lozenge form
ITMI20130210A1 (it)	2013-02-14	2014-08-15	Menarini Lab	Composizioni farmaceutiche contenenti dexketoprofene e tramadolo

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3181998A (en)	1960-08-12	1965-05-04	Joseph L Kanig	Tablet disintegration
DE1617343B2 (de)	1967-04-21	1976-04-22	CH. Boehringer Sohn, 6507 Ingelheim	Traegermasse fuer arzneimitteltabletten
US4517179A (en)	1983-04-29	1985-05-14	Pennwalt Corporation	Rapid dissolving, uniform drug compositions and their preparation
US4600579A (en)	1983-06-07	1986-07-15	Mallinckrodt, Inc.	N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
EP0147780A3 (en) *	1984-01-03	1987-03-11	Merck & Co. Inc.	Drug delivery device
JPH0830005B2 (ja) *	1985-09-25	1996-03-27	ゲルゲリイ、ゲルハルト	崩壊性錠剤とその製造方法
CH675537A5 (pl)	1988-03-25	1990-10-15	Ciba Geigy Ag
US5211957A (en) *	1988-03-25	1993-05-18	Ciba-Geigy Corporation	Solid rapidly disintegrating dosage form
US5254355A (en)	1992-05-29	1993-10-19	Kraft General Foods, Inc.	Process for beverage tablets and products therefrom
DE4329794C2 (de) *	1993-09-03	1997-09-18	Gruenenthal Gmbh	Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung

1995
- 1995-08-19 DE DE19530575A patent/DE19530575A1/de not_active Withdrawn
1996
- 1996-05-29 MY MYPI96002047A patent/MY113908A/en unknown
- 1996-07-17 PT PT96111483T patent/PT759296E/pt unknown
- 1996-07-17 DK DK96111483T patent/DK0759296T3/da active
- 1996-07-17 DE DE59607710T patent/DE59607710D1/de not_active Revoked
- 1996-07-17 SI SI9630318T patent/SI0759296T1/xx unknown
- 1996-07-17 EP EP96111483A patent/EP0759296B1/de not_active Revoked
- 1996-07-17 ES ES96111483T patent/ES2164198T3/es not_active Expired - Lifetime
- 1996-07-17 AT AT96111483T patent/ATE205708T1/de not_active IP Right Cessation
- 1996-07-30 BR BR9604034A patent/BR9604034A/pt not_active Application Discontinuation
- 1996-08-06 AU AU61941/96A patent/AU703310B2/en not_active Ceased
- 1996-08-07 CN CN96110917A patent/CN1102385C/zh not_active Expired - Fee Related
- 1996-08-08 CA CA002182939A patent/CA2182939C/en not_active Expired - Fee Related
- 1996-08-08 NZ NZ299141A patent/NZ299141A/en not_active IP Right Cessation
- 1996-08-09 JP JP21122196A patent/JP4074675B2/ja not_active Expired - Fee Related
- 1996-08-09 CZ CZ19962359A patent/CZ289167B6/cs not_active IP Right Cessation
- 1996-08-09 PE PE1996000597A patent/PE8298A1/es not_active Application Discontinuation
- 1996-08-09 SK SK1042-96A patent/SK281779B6/sk not_active IP Right Cessation
- 1996-08-12 AR ARP960103957A patent/AR003476A1/es not_active Application Discontinuation
- 1996-08-14 PL PL96315749A patent/PL184785B1/pl not_active IP Right Cessation
- 1996-08-14 UY UY24308A patent/UY24308A1/es not_active IP Right Cessation
- 1996-08-16 NO NO19963430A patent/NO313486B1/no not_active IP Right Cessation
- 1996-08-16 RU RU96116411/14A patent/RU2174837C2/ru not_active IP Right Cessation
- 1996-08-16 ZA ZA9606985A patent/ZA966985B/xx unknown
- 1996-08-16 HU HU9602266A patent/HU227360B1/hu not_active IP Right Cessation
- 1996-08-16 IL IL11908096A patent/IL119080A/en not_active IP Right Cessation
- 1996-08-19 UA UA96083292A patent/UA41392C2/uk unknown
- 1996-08-19 US US08/699,623 patent/US5776492A/en not_active Expired - Lifetime
2001
- 2001-09-26 GR GR20010401577T patent/GR3036720T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1102385C (zh)	2003-03-05
UA41392C2 (uk)	2001-09-17
DE59607710D1 (de)	2001-10-25
EP0759296B1 (de)	2001-09-19
JP4074675B2 (ja)	2008-04-09
HU9602266D0 (en)	1996-10-28
CA2182939A1 (en)	1997-02-20
HUP9602266A2 (en)	1997-12-29
UY24308A1 (es)	1996-08-27
CA2182939C (en)	2007-06-19
CZ289167B6 (cs)	2001-11-14
RU2174837C2 (ru)	2001-10-20
JPH09110684A (ja)	1997-04-28
SI0759296T1 (pl)	2001-12-31
PE8298A1 (es)	1998-03-28
EP0759296A1 (de)	1997-02-26
BR9604034A (pt)	1998-06-09
CZ235996A3 (en)	1997-02-12
DK0759296T3 (da)	2001-11-26
NO963430L (no)	1997-02-20
PL315749A1 (en)	1997-03-03
GR3036720T3 (en)	2001-12-31
AU703310B2 (en)	1999-03-25
US5776492A (en)	1998-07-07
NO963430D0 (no)	1996-08-16
AR003476A1 (es)	1998-08-05
ZA966985B (en)	1997-02-24
SK104296A3 (en)	1997-05-07
AU6194196A (en)	1997-02-27
MX9603140A (es)	1997-07-31
MY113908A (en)	2002-06-30
CN1145780A (zh)	1997-03-26
PT759296E (pt)	2002-03-28
SK281779B6 (sk)	2001-07-10
DE19530575A1 (de)	1997-02-20
PL184785B1 (pl)	2002-12-31
NZ299141A (en)	1997-12-19
HU227360B1 (en)	2011-04-28
ES2164198T3 (es)	2002-02-16
ATE205708T1 (de)	2001-10-15
HUP9602266A3 (en)	1998-10-28
HK1010100A1 (en)	1999-06-11
NO313486B1 (no)	2002-10-14
IL119080A0 (en)	1996-11-14

Legal Events

Date	Code	Title
2002-02-10	FF	Patent granted
2002-02-10	KB	Patent renewed
2002-09-12	KB	Patent renewed
2006-10-04	KB	Patent renewed
2010-11-30	KB	Patent renewed
2015-03-31	MM9K	Patent not in force due to non-payment of renewal fees

Publication	Publication Date	Title
CA2182939C (en)	2007-06-19	A rapidly disintegrating medicinal form of tramadol or a tramadol salt
KR100477293B1 (ko)	2005-03-17	플래쉬-용융 경구 투여 제형
EP1058538B2 (en)	2012-04-11	Fast disintegrating tablets
IL165523A (en)	2011-07-31	Orally disintegrating tablets with a high dissolution rate along with very good mechanical properties and process for obtaining them
AU2003259336A1 (en)	2004-03-11	Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
ZA200508361B (en)	2006-12-27	Orally disintegrating tablets
KR20100028624A (ko)	2010-03-12	급속 붕해 정제의 제조를 위한 제약 제제
SK284551B6 (sk)	2005-06-02	Farmaceutický prípravok vo forme šumivej tablety
CA2645629C (en)	2014-04-29	Orodispersible domperidone tablets
RU2500388C2 (ru)	2013-12-10	Маннит, распадающийся в полости рта
JP4551627B2 (ja)	2010-09-29	口腔内崩壊錠剤の製造方法
JP2000178182A (ja)	2000-06-27	崩壊性組成物
AU2003215706B8 (en)	2003-09-02	Orodispersible pharmaceutical composition comprising ivabradine
EA018071B1 (ru)	2013-05-30	Изомальтсодержащая смесь для получения быстро разрушающихся таблеток, способ ее получения и таблетка
AU2003215708B9 (en)	2003-09-02	Orodispersible pharmaceutical composition comprising perindopril
JP5584509B2 (ja)	2014-09-03	口腔内崩壊錠剤
JP2001039894A (ja)	2001-02-13	圧縮タブレットのための結合剤および崩壊剤として使用される時の賦形剤の性質の増強剤としての直接圧縮性の澱粉
EP1684728B1 (en)	2009-09-16	Non-effervescent form of sodium naproxen comprising i.a. sodium hydrogen carbonate
WO2004089343A1 (en)	2004-10-21	Water soluble tablets
KR100642966B1 (ko)	2006-12-22	트라마돌 하이드로클로라이드를 함유하는 정제
MXPA96003140A (en)	1997-12-01	Rapid desintegration medicine based on detramadol or a trama salt
HK1010100B (en)	2002-04-12	Rapidly disintegrating formulation comprising tramadol or a tramadol salt
HK1094152B (en)	2010-03-12	Orodispersible pharmaceutical composition of an antithrombotic compound